Micropapillary bladder cancer: A review of Léon Bérard Cancer Center experience

被引：26

作者：

Heudel P. ^{[1
]}

El Karak F. ^{[1
]}

Ismaili N. ^{[1
]}

Droz J.-P. ^{[1
]}

Flechon A. ^{[1
]}

机构：

[1] Léon Bérard Cancer Center, 69008 Lyon

来源：

BMC Urology | / 9卷 / 1期

关键词：

Bladder Cancer; Radical Cystectomy; Urothelial Carcinoma; Pelvic Lymph Node Dissection; Node Positive Disease;

D O I：

10.1186/1471-2490-9-5

中图分类号：

学科分类号：

摘要：

Background. Micropapillary bladder cancer is a rare and aggressive variant of urothelial carcinoma. A retrospective review of our experience in management of patients with muscle-invasive or metastatic micropapillary bladder cancer was performed to better define the behavior of this disease. Methods. We reviewed the records of the 11 patients with micropapillary bladder cancer who were evaluated and treated at Léon Bérard Cancer Center between 1994 and 2007, accounting for 1,2% of all urothelial tumors treated in this institution. Results. Mean patients age was 60 years. The majority of patients (72%) were diagnosed after 2004. After a median follow-up of 31.7 months, median overall survival was 19 months. Two patients presented with stage II, one with stage III and eight with stage IV disease All 5 patients who had node positive metastases and treated with radical surgery and adjuvant chemotherapy relapsed and had a disease free survival of 9.6 months. Conclusion. Micropapillary bladder cancer is probably an underreported variant of urothelial carcinoma associated with poor prognosis. Adjuvant chemotherapy might have a questionable efficacy and the optimal treatment strategy is yet to be defined. © 2009 Heudel et al.

引用

共 19 条

[1]

Amin M.B., Ro J.Y., El-Sharkawy T., Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma, Am J Surg Pathol, 18, 12, pp. 1224-32, (1994)

[2]

Johansson S.L., Borghede G., Holmang S., Micropapillary bladder carcinoma: A clinicopathological study of 20 cases, Journal of Urology, 161, 6, pp. 1798-1802, (1999)

[3]

Sobin L.H., Wittekind C., TNM classification of tumours of the urinary bladder, TNM Classification of Malignant Tumors, pp. 29-31, (1997)

[4]

Hendrickson M., Ross J., Eifel P., Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma, Am J Surg Pathol, 6, 2, pp. 93-108, (1982)

[5]

McDougall I.R., Camargo C.A., Treatment of micropapillary carcinoma of the thyroid: Where do we draw the line?, Thyroid, 17, 11, pp. 1093-1096, (2007)

[6]

Siriaunkgul S., Tavassoli F.A., Invasive micropapillary carcinoma of the breast, Mod Pathol, 6, 6, pp. 660-2, (1993)

[7]

Amin M.B., Tamboli P., Merchant S.H., Ordonez N.G., Ro J., Ayala A.G., Ro J.Y., Micropapillary component in lung adenocarcinoma: A distinctive histologic feature with possible prognostic significance, American Journal of Surgical Pathology, 26, 3, pp. 358-364, (2002)

[8]

Samaratunga H., Khoo K., Micropapillary variant of urothelial carcinoma of the urinary bladder

[9]

a clinicopatholigical and immunohistochemical study, Histopathology, 45, 1, pp. 55-64, (2004)

[10]

Kuroda N., Tamura M., Ohara M., Hirouchi T., Mizuno K., Miyazaki E., Invasive micropapillary carcinoma of the urinary bladder: An immunohistochemical study of neoplastic and stromal cells, International Journal of Urology, 13, 7, pp. 1015-1018, (2006)

← 1 2 →